Protara Therapeutics, Inc. Share Price & Technical Analysis
TARA · $3.92 (-1.26%)
Healthcare / Biotechnology
$3.92
-1.26%
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline…
Price chart
Seasonality
Jun has 0 positive and 5 negative years (last 5 years shown)
-15% return in Jun, -14% avg return in past 3 year Jun month.
-20% return in 2026, 60% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 31% | -10% | -17% | 2% | -11% | -15% | – | – | – | – | – | – | -20% |
| 25 | -8% | -20% | 13% | -17% | -17% | -3% | 0% | 3% | 39% | 18% | 40% | -27% | 22% |
| 24 | 32% | 84% | -13% | -27% | -7% | -25% | 5% | -9% | -10% | 39% | 20% | 77% | 165% |
| 23 | 27% | 6% | -14% | 3% | -12% | -14% | 8% | -15% | -23% | -25% | 15% | 36% | -8% |
| 22 | -24% | -13% | 9% | -29% | -8% | -12% | 3% | 17% | -14% | 3% | 13% | -29% | -84% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$208.24M
P/E ratio
—
52W high
$7.82
52W low
$2.77
Volume
1,65,802
Beta
1.45
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹35,920
Abbott Laboratories Cede…
₹33,540
Eli Lilly And Company Ce…
₹30,700
Unitedhealth Group Inc C…
₹18,590
₹7,059
Frequently asked questions
- What is Protara Therapeutics, Inc. share price today?
- Protara Therapeutics, Inc. (TARA) last traded around $3.92 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does TARA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TARA. Download the app for real-time alerts.
- How can I analyze Protara Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.